316 related articles for article (PubMed ID: 20132366)
1. Considerations for the use of progestin-only contraceptives.
Freeman S; Shulman LP
J Am Acad Nurse Pract; 2010 Feb; 22(2):81-91. PubMed ID: 20132366
[TBL] [Abstract][Full Text] [Related]
2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
3. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
4. Long-acting contraceptives in adolescents.
Tolaymat LL; Kaunitz AM
Curr Opin Obstet Gynecol; 2007 Oct; 19(5):453-60. PubMed ID: 17885461
[TBL] [Abstract][Full Text] [Related]
5. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
[TBL] [Abstract][Full Text] [Related]
7. Ask the experts: progestin-only contraceptives.
Hatcher RA; Schnare S
Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
[TBL] [Abstract][Full Text] [Related]
8. Progestin-only injectables offer many advantages.
Finger WR
Netw Res Triangle Park N C; 1995 Jun; 15(4):16-20. PubMed ID: 12289828
[TBL] [Abstract][Full Text] [Related]
9. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
London RS
J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
[TBL] [Abstract][Full Text] [Related]
10. Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling.
Freeman S
J Am Acad Nurse Pract; 2004 Jun; 16(6):226-38. PubMed ID: 15264608
[TBL] [Abstract][Full Text] [Related]
11. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.
Kaunitz AM
Int J Fertil Womens Med; 1999; 44(2):110-7. PubMed ID: 10338269
[TBL] [Abstract][Full Text] [Related]
12. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
13. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
14. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
15. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
16. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
Greenspan A
Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
[TBL] [Abstract][Full Text] [Related]
17. Injectable and implantable contraceptives.
Cullins VE
Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
[TBL] [Abstract][Full Text] [Related]
18. Weighing risks against benefits in contraceptive safety.
Akhter HH
Draper Fund Rep; 1983 Aug; (12):20-2. PubMed ID: 12338977
[TBL] [Abstract][Full Text] [Related]
19. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
American Health Consultants
Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
[TBL] [Abstract][Full Text] [Related]
20. Depo-Provera use in an Australian metropolitan practice.
Fraser IS; Dennerstein GJ
Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
